Connect with us

Investment

Perfect Holiday Gifts For Traders: 10 Must-Read Investment Classics To Expand Your Brain (And Bank Account) – Yahoo Finance

Published

 on


TipRanks

The 5G Revolution Could Send These 3 Stocks Higher

5G is here. The new networks are online and expanding, and customers – individual consumers, institutional users, and industrial applications – are starting to take advantage of the new technology. The advantages of 5G are already well-known: faster connections, more efficient upload and download capability, lower latency, greater security. 5G tech is essential for developing the full potential of autonomous vehicles and IoT projects. How it will impact ordinary life remains to be seen.Some of Wall Street’s top analysts have been taking the measure of the new network, and its probably effect on related companies – and their stocks. Using TipRanks database, we’ve pulled up the latest data on three such stocks that the analysts have tapped for gains in the growing 5G environment. CommScope Holding (COMM)We will start with CommScope, a hardware provider for network infrastructure. The company produces antennas for building and tower installation, base stations, and outdoor wireless system power supplies. As a holding company, these CommScope products are produced and marketed by subsidiaries, to customers worldwide.The company announced last month a partnership with Nokia on a passive-active antenna platform, promising a faster 5G rollout for customers. And earlier this month, CommScope announced a contract with the city of Wyandotte, Michigan, for networking installation, including 5G, and giving the company access to over 25,000 potential customers.CommScope reported $2.17 billion in Q3 revenue, up 3% year-over-year. The Broadband segment showed 20% year-over-year growth, and the free cash flow hit $350 million. JPMorgan’s 5-star analyst Samik Chatterjee elaborates on CommScope forward potential: “Our constructive view on shares of CommScope is led by expectations for an improving outlook for the Outdoor Wireless Segment which stands positioned to benefit from the ramp in 5G densification efforts for wireless networks, in combination with continuing resilient spending from cable/broadband networks.””We expect the pace of investments in the wireline network to continue, led by bandwidth requirements to support peak usage, in addition to tailwinds stemming from initiatives such as RDOF and reclamation of satellite spectrum for 5G,” the analyst added.In line with these comments, Chatterjee rates the stock an Overweight (i.e. Buy), and his $18 price target suggests a 35% upside in the coming year. (To watch Chatterjee’s track record, click here)Chatterjee is broadly in line with the rest of Wall Street, which has assigned COMM slightly more “buy” ratings than “holds” over the past three months — and sees the stock growing about 19% over the next 12 months, to a target price of $15.80. (See COMM stock analysis on TipRanks)Crown Castle (CCI)The next stock on our list, Crown Castle, operates as a real estate investment trust, owning and managing cell network assets, including towers and transmitter locations. The company boasts over 40,000 towers, 70,000 operational small cells, and 80,000 miles of fiberoptic lines. Crown Castle’s network is part of the shared infrastructure supporting the wireless communications system in the US.The expansion of 5G networks has been good to Crown Castle, and the company has seen growth and expansion.In November, Crown Castle signed an agreement with DISH, which is looking to expand its 5G footprint. The lease agreement gives DISH rental rights on up to 20,000 towers, and includes fiber transport.Quarterly revenues have held steady between $1.4 and $1.49 billion all year, with Q3, the most recent, coming at the latter value. The company saw site rental revenue gain 4% yoy. Customer rollouts to 5G, and consequent need for additional tower sites, underlies the sound financial results.The sound quarterly results allowed the company to increase its quarterly dividend by 11%. Common share holders now receive $1.33 per common share, annualizing to $5.32 and giving a yield of 3.4%.Deutsche Bank analyst Matthew Niknam sees the DISH deal as part of an overall positive picture for Crown Castle: “CCI is poised to be the early beneficiary of multiple new industry catalysts in upcoming years, including DISH’s 5G build and C-Band spectrum deployments.””Specifically, we believe its agreement with DISH for up to 20k sites puts it in a premier position to be the tower partner of choice, at least early on. Our analysis indicates DISH could easily account for 10% of CCI’s Tower site leasing revenue by 2027E, with the agreement (conservatively) adding $15/share in value for CCI. Second, with ~70% of CCI’s sites located in the top 100 markets, we believe its portfolio over indexes to markets most likely to see initial C-Band builds,” the analyst added. To this end, Niknam rates CCI a Buy along with a $180 price target. This figure implies a 17% upside from current levels. (To watch Niknam’s track record, click here)So, that’s Deutsche Bank’s view, let’s turn our attention now to rest of the Street: CCI’s 3 Buys and 2 Holds coalesce into a Moderate Buy rating. Should the $170.25 average price target be met, about 11% upside could be in store. (See CCI stock analysis on TipRanks)Sierra Wireless (SWIR)Based in British Columbia, Canada, Sierra Wireless designs and manufactures wireless equipment for an international customer base. The company products include machine-to-machine and mobile computing devices for use on wireless networks, as well as modems, routers, and gateways for mobile broadband wireless. Sierra holds over 550 unique patents.Sierra’s focus on machine-to-machine systems make its hardware especially valuable for IoT applications. The company offers 5G capable routers and broadcast solutions for IoT networks, as well as the first 5G enabled vehicle router on the market.Turning to the financials and the stock, we see the company moving in two directions at once. Quarterly revenues have been falling this year, and Q3 came in at just $113 million – far down from the $144 million reported in Q2. While the quarter was generally down, the automotive business did show a 3.6% yoy increase.The company’s stock, however, has been on an upward trajectory, and with a 49% year-to-date gain has outperformed the S&P 500 index.Among the bulls is Colliers analyst Charles Anderson who calls SWIR a “5G IoT play.” Anderson rates the stock a Buy along with a $20 price target. This target indicates the extent of his confidence – it implies a 40% one-year upside. (To watch Anderson’s track record, click here)Backing his stance, Anderson writes, “We like the combination here of management/Board upgrades (CEOs that led turnarounds at IDTI and LSCC recently joined the Board); business model transition toward higher margin recurring revenue; 5G product cycle exposure; and depressed valuation relative to both peers and historicals…””Sierra is in the process of transforming itself from a low margin supplier of cellular connectivity hardware to a higher margin supplier of full stack cellular IoT (hardware/software/service). This is both a better business model and a more compelling offering to customers,” the analyst added.All in all, Sierra has an even split among the recent reviews, 2 Buys and 2 Holds, making the analyst consensus rating a Moderate Buy. (See SWIR stock analysis on TipRanks)To find good ideas for 5G stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.

Let’s block ads! (Why?)



Source link

Continue Reading

Investment

Feel-good funds with positive returns draw legions of responsible investing fans – OrilliaMatters

Published

 on


CALGARY — Growing numbers of Canadian investors are putting their money where their hearts are and finding that investing in companies that share their convictions can also deliver respectable returns.

But while options for socially responsible investing (SRI) or investing in companies based on their environmental, social and governance (ESG) ratings are growing, so too are challenges in finding the right investment that also provides growth to meet personal financial goals.

“For an investor, it’s a wonderful time to help make the change you want to see in the world with your money,” said Rajan Bansi, head of RBC InvestEase, the bank’s online investment management service.

He said InvestEase’s ESG portfolios have outperformed its standard portfolios by about 100 basis points over the past two years and are expected to do just as well over a five-to-seven-year market cycle.

“”When you look at ESG investing, right now more than ever, it’s important for Canadians that their investments are reflective of their personal values,” agreed Joe Reid, vice-president of wealth management and impact investing for Vancouver City Savings Credit Union (Vancity).

He said Vancity’s SRI global equity fund outperformed the MSCI World Index, a global equity performance measure, by more than 20 per cent last year, and its Canadian SRI equity fund beat the TSX composite index by over 10 per cent.

The total value of assets under management in Canadian responsible investment funds jumped to $3.2 trillion in 2019, a gain of 48 per cent over two years, according to a trends report from the Responsible Investment Association published in November.

The report found that such funds represented about 62 per cent of Canada’s investment industry, up from 51 per cent two years earlier. It counted no less than seven different categories or types of funds in its survey.

Willis Langford of Langford Financial Inc., a retirement income adviser in Calgary, says he’s hearing the buzz but hasn’t had many clients ask about switching to responsible investing as yet.

He says when they do, he tends to rely on third-party independent rating agencies to figure out which funds have the best ESG or SRI records — and still make money.

“You invest to earn money in a responsible way but it still has to do both,” he said.

At RBC InvestEase, its ESG fund is made up of investments in companies based on how they score in 37 risk areas, Bansi said.

It won’t make any investments in names involved with civilian firearms, conventional weapons, tobacco or “severe controversies,” but it rates the rest and invests more heavily in those with higher scores.

“I consider ESG to be a risk management approach,” he said, noting that “bad actors” tend to have higher costs of business than responsible companies and are therefore under-represented in the ESG fund.

He said the bank is looking at expanding its offerings to give customers more choices in terms of differing shades of responsible investing.

Vancity, which recently set a goal to achieve net-zero carbon emissions from its entire lending portfolio by 2040, has six no-go industries for its SRI investments: fossil fuels, pornography, gambling, military weapons, nuclear power and tobacco.

It also gets involved in corporate activism by urging the companies it supports to make needed changes, said Reid, adding investors need to beware of “greenwashing,” where companies try to disguise or hide their poor habits.

Both Bansi and Reid said it’s important to consult financial advisers and tax experts when making extensive changes to your existing investment portfolio.

There are fewer tax implications when transferring investments inside a registered fund like an RRSP or TFSA but selling a non-registered investment can trigger capital gains and losses that can affect your tax bill and should be done carefully, possibly over several years, they said.

In the past, Reid said, responsible investing was thought to be a high-cost, high-risk, low-reward way to manage your financial future.

“The reality is that investing responsibly no longer means that. Nowadays, investing responsibly is just good business.”

This report by The Canadian Press was first published Jan. 28, 2021.

Dan Healing, The Canadian Press

Let’s block ads! (Why?)



Source link

Continue Reading

Investment

UK consumers lose £78m in investment and pension scams – Yahoo Movies Canada

Published

 on


GlobeNewswire

Outlook on the Examination Glove Global Market to 2026 – by Material, Sterility, Type and Geography

Dublin, Jan. 28, 2021 (GLOBE NEWSWIRE) — The “Examination Glove Market – Forecasts from 2021 to 2026” report has been added to ResearchAndMarkets.com’s offering. The global examination glove market is expected to grow at a compound annual growth rate of 10.51% over the forecast period to reach a market size of US$10,887.626 million in 2026 from US$5,975.957 million in 2020. Examination gloves are disposable gloves designed to aid medical practitioners by providing them protection from cross-contamination from patients. The demand for examination gloves will increase owing to the rising demand for healthcare services worldwide. Moreover, the demand for examination gloves will also snowball due to the growing adoption of hygienic and cleaner medical practices. However, the environmental concerns caused by the use of synthetic material and health concerns by the use of powdered gloves will restrain the market growth during the forecasted period. The North American and European regions will have a significant share in the market due to high investment in the medical and healthcare field. The Asia Pacific market will also see ample growth opportunities on account of rising investment in the healthcare segment and an increasing number of medical cases in the region.Increasing Healthcare Budget To drive the Market GrowthHealthcare has become one of the imperative sectors, both in terms of employment and revenue. Healthcare comprises medical devices, medical equipment, hospitals, clinics, and others. With the increasing population, worldwide, it has become imperative to spend substantial capital on healthcare, globally. According to the United Nations, the global population is expected to surge by at least 2 billion people, in the next 30 years. The population would rose from 7.7 billion in the year 2019 to 9.7 billion, in the year 2050. These trends show the importance of healthcare spending. The United States health care spending surged by 4.6% in the year 2019, to reach approx. USD 3.8 trillion, or around USD 11,582 per person. The overall share of GDP related to healthcare budget or spending was around 17.7% in the year 2019. According to the United States National Healthcare Expenditure, retail spending for medical products such as surgical gloves and dressings, surged by 5.6% to around USD 82.1 Billion in the year 2019, compared to an approximate rate of 3.8% in the year 2018. The growth in healthcare spending in the country continued to surge in the year 2020, because of the COVID-19 Pandemic. In India, the healthcare sector is growing due to increasing expenditure by private and public players. According to the Indian Brand Equity Foundation, a trust established by the Indian Ministry of Commerce, the Indian Healthcare Market has been growing at an 18% CAGR rate. The overall government spending on Healthcare increased from 1.3% of the GDP in the year 2016 to 1.6% in the year 2020. According to the data released by the Department for Promotion of Industry and Trade, Diagnostic Centers and Hospitals attracted Foreign Direct Investment of USD 6.72 Billion, between the year 2000 and 2020. These developments had a positive effect on the examination gloves market, as surgical and examination gloves are an imperative part of the medical equipment market. The Government of India aims to surge healthcare spending to 3% of the GDP, by the year 2022. In Europe, healthcare spending continues to surge at an exponential rate. According to Eurostat, on average in the European Union, healthcare spending had been around 9.9% of overall GDP in the year 2018. Among the European Union Member States, the biggest healthcare spending was recorded in Germany, which spends around 11.5% of the GDP, followed by France (11.3%), and Sweden, which was at 10.9%. In comparison to the population size, healthcare expenditure was maximum among the European Union member states in Denmark, Luxembourg, and Sweden.Competitive AnalysisThe manufacturers and producers, worldwide, engage and spend a significant sum of capital in designing, manufacturing, and distributing the gloves and other related products to different end-users, such as hospitals, clinics, etc. by using novel and innovative technologies. Government spending on infrastructure development also provides an opportunity for manufacturers, producers, and suppliers, worldwide. For Instance, In February 2019, The Government of India established a novel AIIMS (All India Institute of Medical Sciences) in Haryana, India, at a considerable cost of USD 180.04 million. Other infrastructure development, around the world, also gives provides output to the examination gloves market. In January 2021, Cincinnati, United States, announced the development and construction of a novel 60-bed hospital and a new medical complex, on a 30-acre area, with the cost of around USD 156 million. The construction of the hospital is expected to be completed in the year 2023, and the hospital would have advanced medical equipment and high-quality examination, surgical, and other related gloves. Companies and manufacturers have been developing novel gloves for healthcare end-users. In January 2021, The SRAM & MRAM Group, two of the major players in the market, announced the decision to produce a premium brand of Nitrile Examination Gloves, under their flagship brand called ‘Walletz4u’. The company had been producing gloves for hospitals, clinics, and other related centres, to help them in fighting the COVID-19 pandemic. In January 2021, Aspen Holdings, one of the major players in the market, announced that the company’s novel established glove-making venture would produce medical-grade examination gloves, for a worth of USD 100 million, for an unnamed third-party distributor. The price would be USD 100 per thousand pieces of gloves. According to the company, the distributor had been an established player in the market.Top Glove Corporation Bhd focuses on maintaining a balance product-mix that allows it to cater to the demand of the emerging as well as developed regions. The company currently has a roughly equitable distribution in the revenue generated between the nitrile and latex gloves, with similar proportion of sales being recording in the developed as well as emerging regions for the company. Moreover, Top Glove Corporation Bhd is anticipating a switch from latex to nitrile gloves in the emerging market to accelerate while glove consumption in the developed regions is also expected to increase. As such, the company planned to add 178 production lines (equivalent to 18.2 billion pieces capacity) in 2020 out which nitrile constitutes approx. 78% of the production line and glove capacity while the remainder share is for vinyl/PVC based gloves. This investment follows the addition of the latex gloves’ capacity in 2019.Hartelega Holdings Berhad is primarily a nitrile centric glove manufacturer with its principal customers in North America and Europe. In fact, they generate approx. 82% of the revenues from the developed region, indicating the preference of nitrile gloves over latex in the developed region. However, the company is targeting the emerging market through its OBM (own-brand manufacturer) gloves, allowing them to have better control over the prices, even though they generate most of the business through the OEM (original equipment manufacturer) channel. In the long-term, Hartelega Holdings Berhad plans to increase their production capacity to 76 billion pieces per annum. Key Topics Covered: 1. Introduction2. Research Methodology3. Executive Summary4. Market Dynamics4.1. Market Overview and Segmentation4.2. Market Drivers4.3. Market Restraints4.4. Porters Five Forces Analysis4.4.1. Bargaining Power of Suppliers4.4.2. Bargaining Power of Buyers4.4.3. The threat of New Entrants4.4.4. Threat of Substitutes4.4.5. Competitive Rivalry in the Industry4.5. Industry Value Chain Analysis5. Global Examination Glove Market Analysis, By Material5.1. Latex5.2. Synthetic6. Global Examination Glove Market Analysis, By Sterility6.1. Sterile6.2. Non-Sterile7. Global Examination Glove Market Analysis, By Type7.1. Powdered7.2. Non-Powdered8. Global Examination Glove Market Analysis, by Geography8.1. Introduction8.2. North America8.2.1. North America Examination Glove Market Analysis, By Material, 2021 to 20268.2.2. North America Examination Glove Market Analysis, By Sterility, 2021 to 20268.2.3. North America Examination Glove Market Analysis, By Type, 2021 to 20268.2.4. By Country8.2.4.1. United States8.2.4.2. Canada8.2.4.3. Mexico8.3. South America8.3.1. South America Examination Glove Market Analysis, By Material, 2021 to 20268.3.2. South America Examination Glove Market Analysis, By Sterility, 2021 to 20268.3.3. South America Examination Glove Market Analysis, By Type, 2021 to 20268.3.4. By Country8.3.4.1. Brazil8.3.4.2. Argentina8.3.4.3. Others8.4. Europe8.4.1. Europe Examination Glove Market Analysis, By Material, 2021 to 20268.4.2. Europe Examination Glove Market Analysis, By Sterility, 2021 to 20268.4.3. Europe Examination Glove Market Analysis, By Type, 2021 to 20268.4.4. By Country8.4.4.1. Germany8.4.4.2. France8.4.4.3. United Kingdom8.4.4.4. Spain8.4.4.5. Others8.5. The Middle East and Africa8.5.1. Middle East and Africa Examination Glove Market Analysis, By Material, 2021 to 20268.5.2. Middle East and Africa Examination Glove Market Analysis, By Sterility, 2021 to 20268.5.3. Middle East and Africa Examination Glove Market Analysis, By Type, 2021 to 20268.5.4. By Country8.5.4.1. Saudi Arabia8.5.4.2. Israel8.5.4.3. Others8.6. Asia Pacific8.6.1. Asia Pacific Examination Glove Market Analysis, By Material, 2021 to 20268.6.2. Asia Pacific Examination Glove Market Analysis, By Sterility, 2021 to 20268.6.3. Asia Pacific Examination Glove Market Analysis, By Type, 2021 to 20268.6.4. By Country8.6.4.1. China8.6.4.2. Japan8.6.4.3. South Korea8.6.4.4. India8.6.4.5. Malaysia8.6.4.6. Others9. Competitive Intelligence9.1. Competitive Benchmarking and Analysis9.2. Recent Deals and Investments9.3. Strategies of Key Players10. Company Profiles10.1. Kanam Latex Industries Pvt. Ltd.10.2. MRK Healthcare10.3. Kossan Rubber Industries10.4. K.S. Surgical Pvt. Ltd.10.5. Surgi Pharma10.6. Curas Ltd.10.7. Cardinal Health10.8. Medline Industries Inc.10.9. Ansell Limited10.10. Sarah Healthcare10.11. Tan Sin Lian Industries Sdn Bhd10.12. Top Glove Corporation10.13. Haratelga10.14. Supermax10.15. Riverstone Holdings For more information about this report visit https://www.researchandmarkets.com/r/jo6pis CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Let’s block ads! (Why?)



Source link

Continue Reading

Investment

5 Common Investment Mistakes to Avoid – Morningstar.ca

Published

 on


Warren Buffett once said: “Success in investing doesn’t correlate with IQ once you’re above the level of 25. Once you have ordinary intelligence, what you need is the temperament to control the urges that get other people into trouble in investing.”

Successful investing requires arguably something even rarer: the ability to identify and overcome one’s own psychological biases. And that doesn’t concern only big (and common) wrong moves, such as trying to time the market, chasing short-term returns, not diversifying enough, or taking too much risk. It also concerns smaller hang-ups that can take a toll on your portfolio.

Here you have five examples of “small” mistakes investors can easily fall into:

Over-Complicating things

Many people think investing is complicated, messy stuff that you couldn’t possibly handle on your own. No wonder so many investors become paralyzed with fear and indecision, and often find themselves in complex or expensive products that they don’t really need. Even if it is true that there are some people (very few) who have delivered tremendous returns by using arcane investment strategies, the rest of us would probably just need a well-built straightforward portfolio.

It is a mistake to assume that simple isn’t necessarily better when often it really is. In fact, most advisers suggest having a simple, broadly exposed equities fund at the core of an investment portfolio rather than anything too specific or niche.

Mistaking “Cheap” For “Not Good”

A general rule of thumb is that “you get what you pay for”. We know, for example, that if we are paying more for a car, we’re usually getting a better car. But this rule doesn’t necessarily hold true in the investing world. Generally speaking, paying less will get you better long-term returns, helping your money compound faster over the years. It is a mistake to think that if a fund charges a little bit more, the manager has to be better – in fact, it has been shown time and again that many active managers consistently fail to outperform the cheapest index funds.

Overlooking Small Numbers

With so much data competing for investors’ attention, it’s easy to overlook the smaller numbers or what seem like small differences. But this can be damaging in the long term, especially when it comes to costs. You might think, for example: “That difference could it possibly make if I pay 1% for a fund versus paying 0.60%”? Well, when that money gets compounded over the years, that can be a huge difference. If you invest €10,000 in a fund charging 0.2%, assuming no capital growth, after 20 years you would have €9,608 left. If the fund charged 1.5%, however, you would have just €7,391 left after that period. In investing, it is a mistake to blow off small numbers because they look unimportant. And the same holds true with inflation: even small percentages on long term make an enormous deal in terms of eroding your purchasing power.

Forgetting the Simple Stuff

Investing is all well and good, but it’s still crucial to have an easily accessible emergency stash of cash in case the unexpected happens. Many experts suggest setting aside at least six to 12 months’ worth of living expenses.

Letting your money sleep in your cash saving account is arguably the worst option (right after putting it under the mattress) – the interest is almost always lower than inflation, so you’re constantly losing money in real terms. When it comes to liquidity, instruments that offer the best risk/reward ratio change very quickly. Therefore, in contrast with your stock and bond investments, where buying and holding is often the right answer, you may have good reason to be more hands-on with your cash accounts.

Listening to the Noise 

Over the years, investors have gained much more access to information. They can get it on 24-hour news, through the internet or via social networks. Plugging into economic data and newspaper headlines will hardly help anyone to better position their portfolio. The whole investment industry tries to invest ahead of the news flow, so by the time we read about it or see it on TV, it’s usually already factored into security prices.

A more effective approach is to let valuations be your guide as to what to do next. Basically, it means that you should periodically rebalance your portfolio, cutting back on the securities that have performed really well, and adding to those areas that look undervalued. That’s a better guide to market performance than the news’ flow.

Let’s block ads! (Why?)



Source link

Continue Reading

Trending